Current Assets

Short- term Investments

Gilead Sciences Short- term Investments decreased by 77.9% to $15.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ3 2025
Last reportedQ1 2026
Metric ID: current_assets_marketable_securities_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$68.00M$15.00M
QoQ Change—-77.9%
Range$15.00M – $68.00M

Short- term Investments at Other Companies

Merck & Co. logo
Merck & Co.MRKView metric
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGNView metric

Frequently Asked Questions

What is Gilead Sciences's short- term investments?
Gilead Sciences (GILD) reported short- term investments of $15.00M in Q1 2026.